BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ricardi U, Badellino S, Filippi AR. Stereotactic radiotherapy for early stage non-small cell lung cancer. Radiat Oncol J 2015;33:57-65. [PMID: 26157674 DOI: 10.3857/roj.2015.33.2.57] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Heredia-ciuró A, Castillo-pérez I, Lazo-prados A, Granados-santiago M, López-lópez L, Ortiz-rubio A, Valenza MC. Radiotherapy-Related Fatigue Associated Impairments in Lung Cancer Survivors during COVID-19 Voluntary Isolation. Healthcare 2022;10:448. [DOI: 10.3390/healthcare10030448] [Reference Citation Analysis]
2 Cheung BMF, Lau KS, Lee VHF, Leung TW, Kong FS, Luk MY, Yuen KK. Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases. Radiat Oncol J 2021;39:254-64. [PMID: 34986546 DOI: 10.3857/roj.2021.00311] [Reference Citation Analysis]
3 Jasper K, Liu B, Olson R, Matthews Q. Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration. Adv Radiat Oncol 2021;6:100750. [PMID: 34401609 DOI: 10.1016/j.adro.2021.100750] [Reference Citation Analysis]
4 Saha A, Beasley M, Hatton N, Dickinson P, Franks K, Clarke K, Jain P, Teo M, Murray P, Lilley J. Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients. Acta Oncol 2021;60:505-12. [PMID: 33491521 DOI: 10.1080/0284186X.2021.1874617] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Aoki S, Yamashita H, Takahashi W, Nawa K, Ota T, Imae T, Ozaki S, Nozawa Y, Nakajima J, Sato M, Anraku M, Nitadori J, Karasaki T, Abe O, Nakagawa K. Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients. Oncol Lett 2020;19:2695-704. [PMID: 32218820 DOI: 10.3892/ol.2020.11407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kang B, Yu T, Kim JH, Park JM, Kim J, Chung E, Kwon SK, Kim J, Wu H. Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer. International Journal of Radiation Oncology*Biology*Physics 2019;105:104-9. [DOI: 10.1016/j.ijrobp.2019.03.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Spencer KL, Kennedy MPT, Lummis KL, Ellames DAB, Snee M, Brunelli A, Franks K, Callister MEJ. Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis. Eur Respir J 2019;53:1801568. [PMID: 30635294 DOI: 10.1183/13993003.01568-2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
8 Jeppesen SS, Matzen L, Brink C, Bliucukiene R, Kasch S, Schytte T, Kristiansen C, Hansen O. Impact of comprehensive geriatric assessment on quality of life, overall survival, and unplanned admission in patients with non-small cell lung cancer treated with stereotactic body radiotherapy. Journal of Geriatric Oncology 2018;9:575-82. [DOI: 10.1016/j.jgo.2018.05.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
9 Albano D, Bilfinger T, Nemesure B. 1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT. Lung Cancer (Auckl) 2018;9:65-71. [PMID: 30197547 DOI: 10.2147/LCTT.S166320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
10 Fleckenstein J, Boda-Heggemann J, Siebenlist K, Gudzheva T, Prakofyeva N, Lohr F, Wenz F, Simeonova-Chergou A. Non-coplanar VMAT combined with non-uniform dose prescription markedly reduces lung dose in breath-hold lung SBRT. Strahlenther Onkol 2018;194:815-23. [PMID: 29802434 DOI: 10.1007/s00066-018-1316-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mitsuyoshi T, Matsuo Y, Shintani T, Iizuka Y, Ueki N, Nakamura M, Mizowaki T. Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors. Clinical Lung Cancer 2018;19:e287-96. [DOI: 10.1016/j.cllc.2017.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kim E, Wu HG, Park JM, Kim JI, Kim HJ, Kang HC. Lung density change after SABR: A comparative study between tri-Co-60 magnetic resonance-guided system and linear accelerator. PLoS One 2018;13:e0195196. [PMID: 29608606 DOI: 10.1371/journal.pone.0195196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Shen X, Diao M, Lu M, Feng R, Zhang P, Jiang T, Wang D. Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol. BMJ Open 2018;8:e018519. [PMID: 29463588 DOI: 10.1136/bmjopen-2017-018519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Jeppesen SS, Hansen NCG, Schytte T, Hansen O. Survival of localized NSCLC patients without active treatment or treated with SBRT. Acta Oncol 2018;57:219-25. [PMID: 28885080 DOI: 10.1080/0284186X.2017.1374558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fanetti G, Bazzani F, Ferrari A, Alterio D, Donghi S, Pounou Kamga F, Orecchia R, Jereczek-fossa B. Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: A case report. Cancer/Radiothérapie 2018;22:57-61. [DOI: 10.1016/j.canrad.2017.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Piperis M, Tsoukalas N. Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer. J Invest Surg 2018;31:448-9. [PMID: 29083938 DOI: 10.1080/08941939.2017.1373877] [Reference Citation Analysis]
17 Wong OY, Yau V, Kang J, Glick D, Lindsay P, Le LW, Sun A, Bezjak A, Cho BCJ, Hope A, Giuliani M. Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy. Clin Lung Cancer 2018;19:e241-6. [PMID: 28941961 DOI: 10.1016/j.cllc.2017.08.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
18 Yoshimura S, Mori K, Kawasaki K, Tanabe A, Aikou S, Yagi K, Nishida M, Yamashita H, Nomura S, Fukushima M, Yamashita H, Yamauchi Y, Seto Y. A surgical case of radiotherapy induced esophageal perforation accompanying pyogenic spondylodiscitis: a case report. Surg Case Rep 2017;3:98. [PMID: 28861738 DOI: 10.1186/s40792-017-0368-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Bellière-Calandry A, Dupic G, Magnier F, Chassin V, Dedieu V, Lapeyre M. [Stereotactic lung radiotherapy: Technical setting up on Novalis Tx® and single centre prospective study of the 100 first malignant pulmonary nodules treated at centre Jean-Perrin]. Cancer Radiother 2017;21:291-300. [PMID: 28522279 DOI: 10.1016/j.canrad.2017.01.016] [Reference Citation Analysis]
20 Song JH, Kang KM, Choi HS, Jeong H, Ha IB, Lee JD, Kim HC, Jeong YY, Cho YJ, Lee SJ, Kim SH, Jang IS, Jeong BK. Comparing the clinical outcomes in stereotactic body radiotherapy for lung tumors between Ray-Tracing and Monte-Carlo algorithms. Oncotarget 2016;7:19045-53. [PMID: 26544622 DOI: 10.18632/oncotarget.5992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
21 Lee H, Fahimian BP, Xing L. Binary moving-blocker-based scatter correction in cone-beam computed tomography with width-truncated projections: proof of concept. Phys Med Biol 2017;62:2176-93. [PMID: 28079527 DOI: 10.1088/1361-6560/aa5913] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
22 Kong M, Hong SE. Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage III non-small cell lung cancer.Onco Targets Ther. 2016;9:7227-7234. [PMID: 27920560 DOI: 10.2147/OTT.S124311] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dempsey PJ, Ridge CA, Solomon SB. Advances in Interventional Oncology: Lung Cancer. The Cancer Journal 2016;22:393-400. [DOI: 10.1097/ppo.0000000000000229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Jeppesen SS, Hansen NG, Schytte T, Nielsen M, Hansen O. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer. Lung Cancer 2016;100:90-5. [PMID: 27597286 DOI: 10.1016/j.lungcan.2016.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
25 Park JM, Park SY, Kim HJ, Wu HG, Carlson J, Kim JI. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy. Radiother Oncol 2016;120:279-85. [PMID: 27401404 DOI: 10.1016/j.radonc.2016.06.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
26 Dupic G, Bellière-Calandry A. [Non-small cell lung cancer irradiation in elderly]. Cancer Radiother 2016;20:322-9. [PMID: 27342942 DOI: 10.1016/j.canrad.2016.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Cerra-Franco A, Diab K, Lautenschlaeger T. Undetected lymph node metastases in presumed early stage NSCLC SABR patients. Expert Rev Anticancer Ther 2016;16:869-75. [PMID: 27279087 DOI: 10.1080/14737140.2016.1199279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Kular H, Mudambi L, Lazarus DR, Cornwell L, Zhu A, Casal RF. Safety and feasibility of prolonged bronchoscopy involving diagnosis of lung cancer, systematic nodal staging, and fiducial marker placement in a high-risk population. J Thorac Dis 2016;8:1132-8. [PMID: 27293829 DOI: 10.21037/jtd.2016.04.06] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
29 Rhodes A, Hillen T. Mathematical Modeling of the Role of Survivin on Dedifferentiation and Radioresistance in Cancer. Bull Math Biol 2016;78:1162-88. [PMID: 27271121 DOI: 10.1007/s11538-016-0177-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
30 Lehto RH. Symptom burden in lung cancer: management updates. Lung Cancer Manag 2016;5:61-78. [PMID: 30643551 DOI: 10.2217/lmt-2016-0001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
31 Yeo SG, Kim MJ. Stereotactic body radiation therapy for the treatment of a post-chemotherapy remnant lung mass in extensive-stage small-cell lung cancer: A case report. Exp Ther Med 2016;12:1185-8. [PMID: 27446341 DOI: 10.3892/etm.2016.3359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]